3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Neoplasms
2
Stomach Neoplasms
1
Pancreatic Neoplasms
1
Pancreatic Ductal Adenocarcinoma (PDAC)
1
Ovarian Neoplasms
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms
1
Interventions
Tamoxifen
12
Specimen Handling
6
Anastrozole
6
Chemotherapy, Adjuvant
5
Radiotherapy
4
Letrozole
4
afimoxifene
3
Mastectomy, Segmental
3
Surgical Procedures, Operative
2
Simvastatin
2
Radiation Dose Hypofractionation
2
Radiation
2
Fish Oils
2
Fatty Acids, Omega-3
2
4,17 beta-dihydroxy-4-androstene-3-one
2
telapristone acetate
1
sargramostim
1
ruxolitinib
1
polyphenon E
1
palbociclib
1
fezolinetant
1
exemestane
1
elacestrant
1
darolutamide
1
bazedoxifene
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
abemaciclib
1
Zoledronic Acid
1
Testosterone
1
Tea
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Carcinoma, Intraductal, Noninfiltrating
×
FAPI-46
×
Clear all
NCT06540872
2026-06-03
MI-CISDIR
Universität Münster
Phase 2
Recruiting
30 enrolled